COO

SELL

The Cooper Companies, Inc.

Healthcare · Rank #332 · Analyzed Jul 13, 2026

$70.70

Current Price

$16.37

Intrinsic Value

-76.8%

Upside/Downside

2/10

Score

2/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score2/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 76.8%

Fair Value Range

Low$10.92

Base (IV)$16.37

High$22.93

Entry Points

Conservative$7.64

Moderate$10.92

Aggressive$11.46

Quality & Moat Breakdown

Return on Equity2.9% → 0/1.0

Debt LevelD/E 33 → 0.5/1.0

Revenue QualityGrowth 9.4%, margin Δ-12.9% +recovery → 1.0/1.0

Moat Strength2.0/5 → 0/1.0

Profit Margins5.6% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.